NCT01566825

Brief Summary

The purpose of this study is to determine whether 75 mg amitriptyline affect the sleep dependent consolidation of procedural memory (visual discrimination task, Karni-Sagi-paradigm).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

March 27, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 29, 2012

Completed
Last Updated

March 29, 2012

Status Verified

March 1, 2012

Enrollment Period

9 months

First QC Date

March 27, 2012

Last Update Submit

March 27, 2012

Conditions

Keywords

amitriptylinesleep dependent memory consolidation

Outcome Measures

Primary Outcomes (1)

  • changes in the visual discrimination task's perception threshold

    Improvement in this task is defined as a decrease in the perception threshold between training and retrieval testing.

    The visual discrimination task's perception treshold is assessed before sleep (day 10 at 6 pm) and after sleep (day 11 at 6 pm).

Secondary Outcomes (1)

  • amount of rapid eye movement (REM) sleep (sleep period time percentage)

    night from day 10 to day 11

Study Arms (2)

Amitriptyline

ACTIVE COMPARATOR
Drug: Amitriptyline

white 8 mm Lichtenstein®

PLACEBO COMPARATOR
Drug: Placebo

Interventions

amitriptyline 25 mg at 9:30 pm, day 10, and 50 mg at 1:30 am, day 11

Also known as: Saroten
Amitriptyline

placebo(white 8 mm Lichtenstein®) at 9:30 pm, day 10, and at 1:30 am, day 11

white 8 mm Lichtenstein®

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • male gender
  • age 18 through 40 years
  • ability to communicate effectively in German

You may not qualify if:

  • shift work within the past 24 months
  • any sleep disorder as measured by the Pittsburgh Sleep Quality Index
  • irregular sleep/wake patterns or extreme chronotype as measured by the Morningness-Eveningness Questionnaire
  • history of any neurologic or psychiatric disorders
  • regular medication intake within the past four weeks
  • contraindications for amitriptyline
  • abnormal electrocardiogram (ECG)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité - Universitätsmedizin Berlin, Department of Physiology CBF

Berlin, 10115, Germany

Location

Related Publications (1)

  • Goerke M, Cohrs S, Rodenbeck A, Kunz D. Differential effect of an anticholinergic antidepressant on sleep-dependent memory consolidation. Sleep. 2014 May 1;37(5):977-85. doi: 10.5665/sleep.3674.

MeSH Terms

Interventions

Amitriptyline

Intervention Hierarchy (Ancestors)

DibenzocycloheptenesBenzocycloheptenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPolycyclic Compounds

Study Officials

  • Dieter Kunz, MD

    Charite University, Berlin, Germany

    STUDY CHAIR
  • Dieter Kunz, MD

    Charite University, Berlin, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of the Research Group Sleep Research and Clinical Chronobiology, Department of Physiology CBF, Charité - Universitätsmedizin Berlin

Study Record Dates

First Submitted

March 27, 2012

First Posted

March 29, 2012

Study Start

August 1, 2008

Primary Completion

May 1, 2009

Study Completion

May 1, 2009

Last Updated

March 29, 2012

Record last verified: 2012-03

Locations